Skip to main content

EW Edwards Lifesciences Corporation

Healthcare

93.26 +1.25 +1.36% Close 11/2
Since 2024-12-02 +30.5%
Open
93.16
High
95.75
Low
87.90
Prev close
92.01
Volume
12.1M
Amplitude
8.53%
P/E
52.9
P/B
5.0
Revenue YoY (TTM)
+14.6%
52W 74.66 96.29

Is Edwards Lifesciences Corporation a buy? Fundamentals and valuation first

As of 2026-10-30

Quality: Good, Momentum: Good, Risk / liquidity: Strong; Valuation: Pricey.

Valuation Pricey Free-cash-flow yield is Good, but TTM P/E is Expensive.
TTM P/E 52.88 84th percentile Expensive
Price / book 4.99 83th percentile Expensive
Free-cash-flow yield (%) 2.7 57th percentile Good
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Good Operating margin, TTM is Top; ROE, TTM is Good.
ROE, TTM (%) 9.46 64th percentile Good
Operating margin, TTM (%) 28.09 81th percentile Top
FCF margin, TTM (%) 22.01 79th percentile Good
Quality Factor Investing: A US Quality Value Backtest
Growth Neutral Revenue growth, TTM YoY is Good, but Diluted EPS growth, TTM YoY is Average.
Revenue growth, TTM YoY (%) 14.55 68th percentile Good
Diluted EPS growth, TTM YoY (%) -74.96 27th percentile Average
Momentum Good All 2 indicators are Good.
60-day return (%) 3.01 77th percentile Good
240-day return (%) 6.62 59th percentile Good
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Strong 20-day dollar volume is Top; 60-day annualized volatility is Good.
20-day dollar volume 316,715,177 95th percentile Top
60-day annualized volatility (%) 23.69 26th percentile Good
Factor Investing Explained: 10 Classic Factors in US Stocks

Edwards Lifesciences Corporation (EW) today

1 quant signals active · As of 2026-10-30

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From Edwards Lifesciences Corporation to every stock like it

AI finds several complementary traits of Edwards Lifesciences Corporation across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Edwards Lifesciences Corporation

Edwards Lifesciences Corporation (EW) peers and tracking

Watchlist

This page refreshes daily after the close. Add Edwards Lifesciences Corporation to your watchlist to track signal changes on your next visit.

Edwards Lifesciences Corporation (EW) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Filed revenue acceleration

Active · now 14.55%

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

13 historical occurrences (since 2019-04-26)

Average forward return after Filed revenue acceleration

20-day: Win 46.2%, Sample 13, Median -0.38%, Excess +0.45%, Beat mkt rate 76.9%

60-day: Win 53.8%, Sample 13, Median +1.34%, Excess +0.31%, Beat mkt rate 53.8%

120-day: Win 66.7%, Sample 12, Median +1.86%, Excess +2.89%, Beat mkt rate 66.7%

120 days after: historical avg +4.73%

20-day -2.45%
60-day +0.39%
120-day +4.73%
20-day
60-day
120-day
Win
46.2%
53.8%
66.7%
Sample
13
13
12
Median
-0.38%
+1.34%
+1.86%
Excess
+0.45%
+0.31%
+2.89%
Beat mkt rate
76.9%
53.8%
66.7%

Over 12 occurrences, 120-day forward avg gained 4.73%, beat the market by 2.89 pts; win rate 66.7%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 1241+4.6% +4.7% 54.8% -10.3%
20-40 165-0.9% -9.3% 37.6% -16.1%
40-60 You are here20Insufficient data
60-80 0Insufficient data
80-100 3Insufficient data

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 52.88, placing it in the 55.0 own-history percentile, inside the 40-60 bucket.

More history: Valuation × momentum analogs, Market-wide momentum baseline, Signals not active now

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
-0.1%
Win rate 57.6% Excess -7.4%
853d
Now
Insufficient data
(23d)
Insufficient data
(0d)
60-day momentum down
+6.8%
Win rate 64.3% Excess -0.8%
588d
+9%
Win rate 95.1% Excess -6.3%
82d
Insufficient data
(3d)

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 99,493 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.42%, a 58.4% positive-return rate, and +3.08 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

22 times historically; 60-day forward avg +1.94%, win rate 54.5%, beating the market by -0.13 pts on average.

Top-quintile 6-month momentum

Pending

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest

21 times historically; 60-day forward avg -0.58%, win rate 61.9%, beating the market by -2.5 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest

24 times historically; 60-day forward avg +5.08%, win rate 70%, beating the market by +0.93 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.